Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10077	Companies
206065	Keywords
136276	Articles
109235	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 04/29/2024 at 07:00, 1 year 10 months ago

Biophytis déploie sa stratégie de partenariat dans le domaine de l’obésité
Biophytis déploie une stratégie de partenariat dans le domaine de l’obésité pour le développement de traitements révolutionnaires. La société recherche des partenaires pour licencier son candidat-médicament BIO101

Biophytis Partenariat Développement Clinique Obésité Candidat-médicament
REGULATED PRESS RELEASE

published on 04/29/2024 at 07:00, 1 year 10 months ago

Biophytis is deploying its partnership strategy in obesity
Biophytis announces partnership strategy for obesity, aiming to license out drug candidate BI0101 to global pharma companies for development, launch, and commercialization. CEO stresses importance of partnering for medical innovation

Biophytis Medical Innovation Obesity Partnership Strategy Drug Candidate
BRIEF

published on 04/24/2024 at 23:05, 1 year 10 months ago

Transfert des ADS de Biophytis du Nasdaq vers le marché OTC

Biophytis Nasdaq Ads Économies OTC
BRIEF

published on 04/24/2024 at 23:05, 1 year 10 months ago

Biophytis Transfers ADSs to OTC Market Following Nasdaq Delisting

Biophytis Euronext Growth Nasdaq Delisting OTC Market Stockholders' Equity
PRESS RELEASE

published on 04/24/2024 at 23:00, 1 year 10 months ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces transfer of ADSs to OTC market, resulting in cost savings. ADSs to trade on OTC Pink, while applying for OTCQB. Company remains listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
PRESS RELEASE

published on 04/24/2024 at 23:00, 1 year 10 months ago

Biophytis annonce le transfert de ses ADS sur le marché OTC
Biophytis annonce le transfert de ses ADS sur le marché OTC, réduisant les dépenses et offrant un meilleur accès aux investisseurs américains. Reste cotée sur Euronext Growth Paris

Euronext Growth Paris Biophytis Biotechnologie Marché OTC Transfert ADS
REGULATED PRESS RELEASE

published on 04/24/2024 at 23:00, 1 year 10 months ago

Biophytis annonce le transfert de ses ADS sur le marché OTC
Biophytis annonce le transfert de ses ADS du Nasdaq vers le marché OTC, réduisant ainsi les coûts. Les ADS seront négociés sur OTC Pink et la demande d'admission sur OTCQB sera faite. Biophytis reste cotée sur Euronext Growth Paris

Biophytis Ads Coûts Transfert Marché OTC
REGULATED PRESS RELEASE

published on 04/24/2024 at 23:00, 1 year 10 months ago

Biophytis Announces Transfer of ADSs to OTC Market
Biophytis announces the transfer of ADSs from Nasdaq to OTC Market, resulting in cost savings. Company to trade on OTCQB while remaining listed on Euronext Growth Paris

Euronext Growth Paris Biophytis Nasdaq OTC Market ADSs
BRIEF

published on 04/19/2024 at 07:05, 1 year 11 months ago

Changement de ratio pour le programme ADR de Biophytis

Biophytis Biotechnologie Marché Boursier Ratio ADS Nouveau Ratio
BRIEF

published on 04/19/2024 at 07:05, 1 year 11 months ago

Biophytis Announces Significant Change in ADR Program Ratio

Biophytis Biotechnology Nasdaq ADR Program Stock Ratio Change

Accesswire

Published on 03/24/2026 at 12:35, 1 hour 1 minute ago

Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 1 hour 3 minutes ago

Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 12:30, 1 hour 6 minutes ago

Orogen Reports Record 2025 Financial Performance and Positions for Continued Growth in 2026
Published on 03/24/2026 at 12:30, 1 hour 6 minutes ago

Sidney Resources Corporation Identifies District-Scale Structural and Hydrothermal System at Warren Project; Survey Confirms Strategic Claim Position Within Core Target Corridor
Published on 03/24/2026 at 12:30, 1 hour 6 minutes ago

Avidian Gold Announces Non-Brokered Private Placement for Gross Proceeds of up to $750,000

View all ACCESSWIRE

EQS Group

Published on 03/24/2026 at 13:23, 12 minutes ago

Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program
Published on 03/24/2026 at 13:05, 30 minutes ago

Fortegra Selects Duck Creek Reinsurance and Clarity to Support Strategic Growth
Published on 03/24/2026 at 13:05, 30 minutes ago

Discovery Life Sciences and Mindpeak Partner to Bring AI Precision to Cancer Biomarker Testing in Global Clinical Trials
Published on 03/24/2026 at 12:53, 42 minutes ago

Original-Research: Aroundtown SA (von First Berlin Equity Research GmbH): Kaufen
Published on 03/24/2026 at 12:37, 58 minutes ago

CENIT concludes fiscal year 2025 with a strong operational Q4 and looks confidently toward the current year (EBITDA Forecast 2026 +46.6%)

Les Echos

Published on 03/24/2026 at 10:58, 2 hours 38 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 2 hours 38 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 5 hours 51 minutes ago

François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 5 hours 51 minutes ago

La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 6 hours 6 minutes ago

Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions

View all LES ECHOS COMFI WIRE